Application and progress of the contrast-enhanced ultrasound liver imaging reporting and data system (CEUS LI-RADS) in "M" lesions
10.3969/j.issn.1001-5256.2022.10.041
- VernacularTitle:超声造影肝脏影像报告与数据系统分类标准在M类病变中的应用及进展
- Author:
Xingni WU
1
;
Shaoshan TANG
1
;
Xiang LI
1
;
Zinan LI
1
Author Information
1. Department of Ultrasound, Shengjing Hospital, China Medical University, Shenyang 110004, China
- Publication Type:Reviews
- Keywords:
Liver Neoplasms;
Contrast Enhanced Ultrasound;
Liver Imaging Reporting And Data System;
Diagnosis
- From:
Journal of Clinical Hepatology
2022;38(10):2412-2415
- CountryChina
- Language:Chinese
-
Abstract:
Clinically, there are still substantial differences between hepatocellular carcinoma (HCC) and non-HCC liver malignancies in terms of risk factors, pathogenesis, biological behaviors, treatment selections, prognosis, and prevention measurement. The liver imaging reporting and data system (LI-RADS) M (LR-M) classification criteria in the contrast-enhanced ultrasound LI-RADS (CEUS LI-RADS) can help differentiate HCC from non-HCC malignancies. This review discussed and summarized recent advancements in differential diagnosis of HCC from non-HCC using the LR-M criteria and speculated future directions in the field, i.e., how CEUS LI-RADS distinguish HCC from intrahepatic cholangiocarcinoma, mixed hepatocellular carcinoma cholangiocarcinoma, and liver metastasized and benign tumors. It also discussed differences between CEUS LI-RADS and CT/MRI LI-RADS in diagnosis of liver neoplasms and Sonazoid Ⓡ modified CEUS LI-RADS in differential diagnosis of HCC from non-HCC.
